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PCardiac Imaging and Stent Failure
Stent Gap by 64-Detector
Computed Tomographic Angiography
Relationship to In-Stent Restenosis, Fracture, and Overlap Failure
Harvey S. Hecht, MD, Sotir Polena, MD, Vladimir Jelnin, MD, Marcelo Jimenez, MD,
Tandeep Bhatti, DO, Manish Parikh, MD, Georgia Panagopoulos, PHD, Gary Roubin, MD, PHD
New York, New York
Objectives The goal of this study was to define the frequency of stent gaps by 64-detector computed tomographic angiogra-
phy (CTA) and their relation to in-stent restenosis (ISR), stent fracture (SF), and overlap failure (OF).
Background SF defined by catheter angiography or intravascular ultrasound has been implicated in ISR.
Methods A total of 292 consecutive patients, with 613 stents, who underwent CTA were evaluated for stent gaps associ-
ated with decreased Hounsfield units. Correlations with catheter coronary angiography (CCA) were available in
143 patients with 384 stents.
Results Stent gaps were noted in 16.9% by CTA and 1.0% by CCA. ISR by CCA was noted in 46.1% of the stent gaps
(p  0.001) as determined by CCA, and stent gaps by CTA accounted for 27.8% of the total ISR (p  0.001). In
univariate analysis, stent diameter 3 mm was the only CCA characteristic significantly associated with stent
gaps (p  0.002), but was not a significant predictor by multivariate analysis. Bifurcation stents, underlying cal-
cification, stent type, location, post-dilation, and overlapping stents were not observed to be predisposing fac-
tors. Excessive tortuosity and lack of conformability were not associated with stent gaps; however, their fre-
quency was insufficient to permit meaningful analysis.
Conclusions Stent gap by CTA: 1) is associated with 28% of ISR, and ISR is found in 46% of stent gaps; 2) is associated with
3-mm stents by univariate (p  0.002) but not by multivariate analysis; 3) is infrequently noted on catheter
angiography; and 4) most likely represents SF in the setting of a single stent, and may represent SF or OF in
overlapping stents. (J Am Coll Cardiol 2009;54:1949–59) © 2009 by the American College of Cardiology
Foundation
ublished by Elsevier Inc. doi:10.1016/j.jacc.2009.06.045o
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srug-eluting stents have revolutionized percutaneous cor-
nary intervention by dramatically reducing the incidence of
n-stent restenosis (ISR). Stent fracture (SF), although a
ommon finding with significant negative clinical implica-
ions in the peripheral vasculature (1–4), has never been
eported in multicenter randomized clinical coronary stent
rials (5–14). However, recent data (15–32) have suggested
hat SF, as defined by catheter coronary angiography (CCA)
r intravascular ultrasound (IVUS) evidence of a gap, may
e a significant contributor to ISR, particularly in sirolimus-
luting stents (15,16). ISR has been extensively evaluated by
4-detector computed tomographic angiography (CTA)
33). This study was designed to determine the character-
stics and relationship of stent gaps on CTA to ISR, SF, and
rom the Lenox Hill Heart & Vascular Institute, New York, New York. Dr. Hecht
s on the Speakers’ Bureau of Philips Medical Systems. Dr. Parikh is a consultant for
edtronic, and is on the Speakers’ Bureau for Cordis and Abbott Vascular.N
Manuscript received April 15, 2009; revised manuscript received May 29, 2009,
ccepted June 2, 2009.verlap failure (OF) by CCA, in those selected for invasive
ngiography.
ethods
opulation. Two hundred ninety-two consecutive pa-
ients, with implantation of 613 stents, undergoing 64-
etector CTA were evaluated retrospectively. The patient
emographics are shown in Table 1. All were referred for
valuation of symptoms. Of the 292 patients, CCA data
ere available in 143, allowing comparison of CTA and
CA findings for 384 stents.
TA protocol. Metoprolol 50 to 100 mg by mouth and/or
mg intravenously4 was administered to reduce the heart
ate to 60 beats/min. The CTA were acquired on the
hilips Brilliance-64 scanner (Philips Medical Systems,
leveland, Ohio) using the 64  0.625-mm detector
onfiguration, 120 kVp, 600 to 1,050 mA, 0.2 pitch, and
tandard or sharp filters (Philips CC and CD filters).
onionic contrast (Ioversol 350 mg/ml at 5 to 6 ml/s) was
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CTA Stent Gap November 17, 2009:1949–59used, followed by 50 ml of saline
at the same rate using a double-
head injector (Optivantage DH,
Mallinkrodt, Cincinnatto, Ohio).
Estimated effective radiation dose
was 13 mSv for men and 18 mSv
for women. The cardiac phase best
demonstrating each artery (usually
75% of the R-R interval) was an-
alyzed using a dedicated CTwork-
station (Philips CT Extended
Brilliance Workspace, Philips
Medical Systems) and a cardiac
adaptive multisegment reconstruc-
ion algorithm. Curved and straightened multiplanar reformat-
ed images were constructed and evaluated for stent separation
nd ISR. All stents were evaluated, irrespective of quality.
DCT stent analysis. SF. Stent gap was diagnosed when
oth of the following criteria were fulfilled on the curved
ultiplanar reformatted images, and on cross-sectional
nalysis of the straightened multiplanar reformatted images:
) partial or complete (circumferential) gap or a “crush”
attern on visual inspection (Fig. 1); and 2) confirmation of
ounsfield units (HU)300 (the lowest HU in the normal
tent areas) at the site of separation, consistent with the
bsence of metallic stent material (Figs. 2 to 7). The length
f the separation (i.e., the distance between the normal stent
dges surrounding the separation) was measured. All stents
ere analyzed; none were considered unevaluable because of
otion artifact or adjacent very dense calcification capable
f producing a gap secondary to shadowing. The CTA
nalysis was performed by 2 independent observers who did
ot partake in the CCA analysis. ISR by CTA was
valuated as previously described (33).
CA. Selective coronary angiography was performed for
linical indications using standard techniques in 143 pa-
ients. The reasons for the nonreferral for invasive angiog-
aphy of the remainder of the patients cannot be accurately
DemographicsTable 1 Demographics
Total
n 292
Male 72.3%
Female 27.7%
Age, yrs 64.20 11.55
Hypertension 77.6%
Hyperlipidemia 92.2%
Smoking 11.0%
Diabetes 26.6%
Stroke 8.6%
Myocardial infarction 42.7%
Statin 84.1%
Aspirin 91.2%
Clopidogrel 67.4%
Abbreviations
and Acronyms
CCA  catheter coronary
angiography
CTA  computed
tomographic angiography
HU  Hounsfield unit
ISR  in-stent restenosis
IVUS  intravascular
ultrasound
OF  overlap failure
SF  stent fracturescertained since the patients were referred for CTA by
any different community physicians with different thresh-
lds and criteria for proceeding to invasive procedures.
tented areas were reviewed by a separate observer who did
ot participate in the CTA interpretation. Stents specifically
escribed as single or overlapped were classified accordingly.
f specific information was unavailable, stented lengths 40
m were considered overlapped; the remainder were clas-
ified as unknown. Under 3-fold magnification, all stents
ere evaluated for ISR, defined as 50%, by caliper
easurement of percent diameter stenosis, and for separa-
ion consistent with SF or OF. Lesions were defined
ccording to the American College of Cardiology/American
eart Association classification (34). SF was classified as
artial or complete separation of stent segments. Excessive
ortuosity was defined as the presence of 2 or more bends
75° proximal to the target lesion; at least 1 proximal bend
90° (35). Conformability was defined as the degree to
hich a stent can bend around its longitudinal axis after
eployment.
IVUS was acquired in only 5 patients, a number too few
o permit meaningful analysis.
tatistical analysis. Descriptive statistics were used to
haracterize demographic and peri-procedural data. Differ-
nces between the 2 groups (gap present vs. gap absent)
ere examined with the Fisher exact test for categorical
ariables or the independent-samples t test for continuous
ariables. Degree of agreement in the stent gap designation
etween the 2 observers was computed using Cohen’s kappa
oefficient. In order to minimize the type I error rate, which
ould result from examining multiple hypotheses, p  0.01
as considered a priori to indicate statistical significance.
ultivariate analysis utilized 2 separate stepwise logistic
egression procedures to identify potential predictors of
racture. The first model included the following demo-
raphic and patient characteristics as predictors: sex, age,
ypertension, hyperlipidemia, smoking, diabetes melli-
us, stroke, history of myocardial infarction, and use of
Present Gap Absent p Value
42 250
59.4% 74.6% NS
41.6% 25.4% NS
 12.84 64.34 11.35 NS
86.8% 79.2% NS
89.7% 92.7% NS
8.1% 11.6% NS
36.8% 24.9% 0.001
7.9% 8.7% NS
39.5% 43.3% NS
82.1% 84.5% NS
89.7% 91.5% NS
74.4% 66.0% NSGap
63.3
Beta-blocker 66.1% 65.2% 71.4% NS
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November 17, 2009:1949–59 CTA Stent Gaptatins, aspirin, clopidogrel, and beta-blockers. The sec-
nd model included all coronary angiography character-
stics as presented in Table 2. A value of p  0.05 was
Figure 1 Stent Gap Patterns
Normal (A), partial (B), crush (C), and complete (D, center, preceded [left] and fo
Figure 2 A 63-Year-Old Female With Recurrent Atypical Chest
(A) Computed tomographic angiography (CTA) curved multiplanar reconstruction (MPR
density consistent with neointimal hyperplasia. (B) Catheter angiography demonstrate
(arrows), but is not seen on a subsequent frame, D. (E) Cross sections obtained from
the presence of metallic stent material. Densities in the normal area were 400 HU.sed to indicate statistical significance in the multivariate
nalyses. All statistical analyses were performed with
PSS version 16.0.2 (SPSS, Chicago, Illinois). The study
[right] by normal areas).
6 Months After Placement of Overlapping Stents in the LAD
ls clear stent separation (arrow) consistent with fracture as well as luminal hypo-
in-stent restenosis (arrow). (C) Stent fracture is evident on a frame without contrast
traightened MPR reveal a low HU of 192 at the separation site, incompatible with
Hounsfield units; LAD  left anterior descending coronary artery.llowedPain
) revea
s mild
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CTA Stent Gap November 17, 2009:1949–59as approved by the Institutional Review Board of Lenox
ill Hospital.
esults
he patient demographics are displayed in Table 1. Stent
ap was noted in 14.4%; diabetic patients were more
requently found in the SF/OF group (p  0.001) but was
ot a significant predictor in a multivariate analysis. The
ean  SD interval between the CCA and CTA studies
as 57.4  130 days.
There were 384 stents in the 143 patients with both CCA
nd CTA data, Stent gap was noted in 16.9% of the stents
y CTA. There were 4 stents with the crush pattern on
TA and 1 with total separation; the remainder had the
artial gap pattern. SF was observed in only 1.0% by CCA;
had total and 2 had partial separation. There was a highly
ignificant association of stent gap by CTA with ISR on
CA (Tables 2 and 3). There were 229 stents in the 159
atients who did not proceed to CCA; stent gap was noted
n 6.6% (p  0.001 compared with those with CCA
Figure 3 A 58-Year-Old Asymptomatic Male 8 Months After Pla
(A) Two areas of separation are noted on the CTA curved MPR (arrows) as well as
reveals significant in-stent restenosis (ISR) (arrow). (C) A single noncontrast fram
(D) Cross sections obtained from the straightened MPR reveal partial absence of
formly higher HU (right). Fx  fracture; RCA  right coronary artery; other abbreviaollow-up). gISR on CCA was noted in 46.1% of stent gaps (p 
.001), and stent gaps accounted for 27.8% of the total ISR
p  0.001). The HU for the gap area was 196.9  81.1
ompared with 481.9  161.8 for the intact portion. The
ap length was 2.3 0.9 mm. Stent gap agreement between
he 2 observers was very strong (kappa  0.904). Stent
mplantation information was available for 124 patients;
here were no differences in the interval between implanta-
ion and the CCA in stents with (median 618 days, range
,851 days) and without (median 559 days, range 2,369
ays) stent gaps. The only CCA characteristic significantly
ssociated with a stent gap by univariate analysis was stent
iameter 3 mm; stent gaps were present in 20.0% of 3
m stents compared with 3.4% of 3-mm stents (p 
.002). By multivariate analysis, stent diameter was not a
ignificant predictor. Stent type, location, length, underly-
ng calcification, post-dilation, and bifurcation stents were
ot predisposing factors (Table 2). Excessive tortuosity and
ack of conformability were not associated with stent gaps;
owever, their frequency was insufficient to permit meaningful
nalysis. There were no differences in the frequency of stent
nt of Overlapping RCA Stents
al hypodensity consistent with neointimal hyperplasia. (B) Catheter angiography
lays complete separation, which is not visible on any subsequent frames.
aterial with HU 300 at both sites (left, middle). The normal area reveals uni-
as in Figure 2.ceme
lumin
e disp
stent m
tionsaps noted in single versus overlapped stents (Table 2).
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November 17, 2009:1949–59 CTA Stent Gapowever, 26.6% of the stents were in the unknown category
nd could not be classified as single or overlapped; 46.6% of the
aps were noted in this group. Due to sample-size limitations,
t is possible that there was not sufficient power to detect
otentially significant predictors in the multivariate analysis.
he sensitivity and specificity of the CTA for detection of ISR
y CCA were 89.3% and 79.2%, respectively.
Figures 2 to 7 demonstrate the CTA and catheter angio-
raphic characteristics of stent gaps. In Figure 2A, there is
bvious separation at an overlap site on the CTA. Highlight-
ng the difficulty inherent in the limited sampling of catheter
ngiographic analysis is the clear gap noted in 1 noncontrast
rame (Fig. 2C), which is totally unapparent in a second frame
Fig. 2D). There was only mild ISR (Fig. 2B).
In Figure 3, there are 2 areas of stent separation by CTA
Fig. 3A), with significant ISR at the more proximal site. As
n Figure 2, a single noncontrast frame revealed the stent
eparation on catheter angiography (Fig. 3C); all other
rames revealed a normal-appearing stent. In both cases,
ross-sectional analyses (Figs. 2E and 3E) revealed HU at
he gap sites that were below the threshold for metallic stent
Figure 4 A 70-Year-Old Female With Exertional Dyspnea 1 Year
(A) CTA curved MPR reveals a stent gap (arrow) associated with luminal hypoden
ISR (B) and an intact stent in a noncontrast frame (C). (D) Cross sections obtain
the gap site (right arrow) and intact stent with HU 400 in the normal area (leftaterial. vA stent gap is noted on CTA in Figure 4A with
atheter angiography revealing only moderate ISR (Fig.
B) and an apparently intact stent (Fig. 4C). Cross-
ectional analysis (Fig. 4D) confirmed the more common
ap fracture pattern and decreased HU associated with
he fracture site.
A totally occluded proximal stent with distal filling of
he stent by collaterals, and 2 stent gaps are seen on CTA
n Figure 5A. Catheter angiography confirmed the total
cclusion (Fig. 5B), but the stent was intact in noncon-
rast frames (Fig. 5C). Cross-sectional analysis confirmed
he gap pattern with clearly decreased HU in the gap
reas. In Figure 6A, CTA demonstrated obvious separa-
ion without ISR. Catheter angiography revealed only
ild ISR, and a single noncontrast frame suggested
artial fracture (Fig. 6B). Cross-sectional analysis (Figs.
C and 6D), as in the previous cases, confirmed the gap
ith decreased HU.
The “crush” pattern is shown in Figure 7A and 7D in an
btuse marginal branch with severe ISR at a hinge point, a
ocation prone to fracture. Nonetheless, fracture was not
r Implantation of a Stent in the Proximal LAD
nsistent with neointimal hyperplasia. Catheter angiography reveals only moderate
the straightened MPR reveal partial absence of stent material and low HU at
. Abbreviations as in Figures 2 and 3.Afte
sity co
ed from
arrow)isible on catheter angiography (Figs. 7B and 7C).
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CTA Stent Gap November 17, 2009:1949–59iscussion
his study is the first to systematically evaluate the signif-
cance of stent gaps defined by CTA. The strong relation-
hip between stent gaps and ISR has significant implications
or the occurrence of SF and OF.
F and ISR. SF has recently been implicated in ISR. In
30 patients undergoing repeat angiography, Lee et al. (15)
oted 10 (1.8%) with SF by angiography. Binary ISR for the
F patients was 70%; all required target lesion revascular-
zation. Predisposing factors were sirolimus stents (100%),
xcessive tortuosity (40%), and stent overlap (50%) with
ncreased rigidity that may act as a fulcrum for metal
eformation. Aoki et al. (16) evaluated 307 sirolimus-
luting stents in 280 patients and noted 8 (2.6%) with SF on
atheter angiography within 8 months of implantation,
onfirmed by IVUS. Binary ISR for the SF patients was
7.5%, and 50% underwent target lesion revascularization.
f the 8 with SF, 7 were at overlapped areas. All were
Figure 5 A 36-Year-Old Male With Atypical Chest Pain 18 Mon
After LAD Stent Implantation During an Acute Myocar
(A) CTA curved MPR reveals 2 stent gaps (arrows) associated with severe lumina
occlusion (B, arrow); an intact stent is noted in a noncontrast frame (C). (D) Cros
rial and low HU at the gap sites (right and left) and intact stent with HU 400 inocated at hinge points. Predisposing factors were RCA SF socation (odds ratio [OR]: 10.00) with greater vessel defor-
ation with cardiac motion, saphenous vein graft location
OR: 35.88), and longer stent length with associated higher
adial forces (OR: 1.04). Lee et al. (17) evaluated 366
atients with sirolimus stents; SF was noted in 10 (2.7%).
f the 26 with ISR, 10 (38.5%) were associated with SF (7
y angiography and 3 by IVUS). ISR was present in 44% of
he SF; 3 (30%) were in overlapped stents. SF was not found
n 30 patients with ISR after bare-metal Bx Velocity (Cordis
orporation, Bridgewater, New Jersey) stent implantation.
n addition to the above series, there are 13 case reports
valuating 14 patients with SF: 10 involved sirolimus-eluting
tents (18–32). Two patients were evaluated by CTA (28,31).
F mechanisms. Proposed mechanisms for SF, in addition
o those discussed above, are low stent conformability,
verexpansion during post-dilation, and bifurcation lesion
ith high angulation. In the present study, stent diameter
3 mm was the only significant predisposing factor for
nfarction
ensity consistent with total occlusion. Catheter angiography confirms the total
tions obtained from the straightened MPR reveal partial absence of stent mate-
rmal area (middle). Abbreviations as in Figure 2.ths
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November 17, 2009:1949–59 CTA Stent Gapresent in 20.0% of 3-mm stents compared with 3.4% of
3-mm stents (p  0.002). However, it was not a signif-
cant predictor in multivariate analysis. Stent length, loca-
ion and type, overlapped stents, post-dilation, underlying
alcification, and bifurcation stents were not significantly
elated. Excessive tortuosity and lack of conformability were
arely noted, and their contribution could not be evaluated.
The high incidence of ISR associated with stent gaps
ost likely results from the absence of drug-elution protec-
ion from neointimal hyperplasia, or a drug-free zone, at the
ap site. Other possibilities include broken struts causing
ocal mechanical stimulation of the vessel wall, resulting in
nflammation and development of intimal hyperplasia, as
ell as local uncovered unstable plaque.
TA diagnosis of SF or OF. The ability of CTA to
onfidently identify stent gaps is dependent not just on dem-
nstration of a “gap,” which may be more apparent than real,
epending on the window settings. Rather, the gap must be
ssociated with HUs below the minimum density of stent
aterial, which is independent of window center and width,
nd the absence of artifact that may contribute to this finding.
he study must be carefully evaluated for shadowing effects of
Figure 6 A 62-Year-Old Male With Dyspnea 9 Months After Ove
(A) CTA curved MPR reveals obvious separation without ISR (arrow). (B) Catheter ang
fracture (bottom) (arrows). (C and D) Cross-sectional analysis confirmed the g
right) stent segments.djacent dense calcification and motion artifacts. iIn the absence of artifacts, the most likely explanations
or the hypodense gap are fracture- or OF-related absence
f strut material. Overinflation, with spreading of struts
ithout true fracture, cannot be excluded. Bifurcation
tents, with inflation into a side branch and possible strut
amage, were not associated with a higher incidence of stent
aps (Table 2). The absence of strut material for a distance
reater than the normal average interstrut distance (1 mm)
s convincing evidence for an uncovered portion of the
rtery. The 46% incidence of ISR in stent gaps and the 28%
ssociation of stent gaps with ISR support the pathologic
ignificance of this observation and the likely presence of SF
r OF, even though there is no confirmatory gold standard.
The most common gap was a hypodense partial gap
uggestive of incomplete SF. The crush pattern, manifested
y a flattening of the stent with a hypodense gap, was less
requent. Only 1 case of total separation was noted.
imitations of catheter angiography and IVUS. The
nfrequency of catheter angiographic identification of stent
eparation in the present series (1.0%) is similar to the 1.8% to
.7% in previously reported studies (15–17). The discrepancy
etween the CTA (16.9%) and catheter angiography frequency
ing LAD Stent Implantation
hy revealed only mild ISR (top) and a single noncontrast frame suggested partial
decreased HU (D, middle), compared with proximal (D, left) and distal (D,rlapp
iograp
ap withn this and previous reports has several possible explanations.
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CTA Stent Gap November 17, 2009:1949–59First, successful detection of SF or OF by catheter
ngiography is directly related to the gap length and
nversely related to deviation of image acquisition from the
lane perpendicular to the gap; overlap of strut edges on
onperpendicular acquisitions may render the gap invisible.
his proof of concept is clearly illustrated in Figures 2 and
, in which the gap was visible only in very few frames and
napparent in all others, in Figure 4 in which the absence of
truts was apparent only by IVUS (not shown), and in
igure 7 with partial SF suggested on a single catheter
ngiographic frame yet evident on IVUS (not shown). The
roblem is magnified by the limited number of acquisitions,
ypically 5 to 8 for the left coronary artery and 2 to 4 for the
ight coronary artery. The 3-dimensional quality of CTA
enders it immune to the issue of image acquisition; the gap
ite can be inspected from every conceivable angle.
Second, lesser degrees of separation may have been
resent in this series compared with prior reports. CTA, as
iscussed above, is very likely more sensitive in detecting
Figure 7 A 59-Year-Old Male With Recurrent Angina 6 Months
(A) CTA curved MPR reveals a stent gap (arrow) without clear evidence for contrast, c
systole (top, arrow) and diastole (bottom, arrow), and an intact stent in noncontrast
ened MPR reveal the “crush” pattern with partial absence of stent material and low H
tions as in Figure 1.esser separation if present. aThird, the CTA stent gap findings may not represent true
F or OF. This is highly unlikely since, as discussed in the
revious text, there is no other plausible explanation for the
ecreased HU (300). Adjacent calcified plaque was not of
ufficient density to produce HU reduction by shadowing, and
ll the studies were of sufficient quality to eliminate other
ources of artifacts as contributors. In addition, the high
requency of catheter angiography-proven ISR associated with
TA stent gaps is similar to the previously reported association
f ISR with SF diagnosed by catheter angiography and
ntravascular ultrasound (15–17). IVUS would seem to be well
uited for SF/OF identification but has not been extensively
valuated. Careful frame-by-frame analysis is essential, and the
lmost ubiquitous presence of superimposed calcification may
ender differentiation of stent material from calcified plaque
ifficult, if not impossible. In addition, the pullback may skip
ver a fracture site. Nonetheless, expert IVUS evaluation might
e expected to yield results similar to CTA. Its highly invasive
ature restricts its use to patients already undergoing catheter
Obtuse Marginal Stenting
ent with severe ISR. (B) Catheter angiography reveals critical ISR at a hinge point in
c and diastolic frames (C, arrow). (D) Cross sections obtained from the straight-
e gap site (right) and intact stent with high HU in the normal area (left). Abbrevia-After
onsist
systoli
U at thngiography.
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November 17, 2009:1949–59 CTA Stent GapThe lower incidence of stent gap in patients not referred for
CA compared with those who underwent invasive evaluation
6.6% vs. 16.9%, p  0.001) may reflect a lower incidence of
SR-related symptoms requiring further testing.
F versus OF. In patients with a gap in a single stent, SF
s the most likely explanation. In prior reports of fracture at
n overlap site, stent separation has always been attributed
Univariate Comparison of Characteristics onCCA in Stents With a d Without Gaps on CTATable 2 Univ iate Comp rison of CharacterCCA in Stents With and Without Ga
Gap Present G
n 384
In-stent restenosis
50% 28.1% (108)
50% 71.9% (276)
Stent type
Sirolimus 19.3% (74)
Paclitaxel 24.0% (92)
Bare-metal 56.8% (218)
Number of stents
Single 65.1% (250)
Overlap 8.3% (32)
Unknown 26.6% (102)
Calcium present
Yes 52.3% (102)
No 47.7% (93)
Bifurcation
Yes 15.5% (30)
No 84.5% (163)
Diameter, mm
3 31.2% (59)
3 68.8% (130)
Length, mm
18 58.1% (104)
18 41.9% (75)
Post-dilation
Yes 33.9% (64)
No 66.1% (125)
Location
LAD 39.9% (153)
LCx 24.0% (92)
RCA 34.5% (132)
LM 1.6% (6)
Proximal 45.5% (172)
Distal 54.5% (206)
*Single versus overlap.
CCA  catheter coronary angiography; CTA  computed tomograp
circumflex coronary artery; LM  left main coronary artery; RCA  rig
elationship of Stent Gap by CTA to ISR by CCATable 3 Relationship of Stent Gap by CTA to ISR by CCA
Present Absent p Value
Gap
% (n) 16.9% (65) 83.1% (319)
In-stent restenosis 27.8% (30) 72.2% (78) 0.001
In-stent restenosis
% (n) 29.3% (108) 70.7% (276)
Stent gap 46.2% (30) 53.8% (350) 0.001wSR  in-stent restenosis; other abbreviations as in Table 2.o fracture rather than to the possibility that the stents were
ever completely overlapped or migrated over time. The
ack of detection by catheter angiography suggests that the
tents appeared successfully overlapped at the time of their
mplantation. However, the intrinsic limited acquisition
ssue is exaggerated by the even more limited number (1 to
) of post-stent acquisitions, and inadequate overlap at the
ime of implantation cannot be excluded. In the present
tudy, stent information was missing for 26.6% of the stents,
hich could not be classified as single or overlapped; 46.6%
f the gaps were noted in this group. Consequently, the true
requencies of possible SF and OF could not be determined.
n the 73.4% with implantation data, stent gaps were
qually present in single versus overlapped stents.
tudy limitations. The patient population represents a ret-
ospective analysis of a consecutive series of stented patients
on
CTA
sent Total p Value
(65) 83.1% (319)
(30) 72.2% (78) 0.001
(35) 87.3% (241)
(9) 87.8% (65)
(17) 81.5% (75) NS
(39) 82.1% (179)
(32) 87.2% (218) NS*
(2) 93.7% (30)
(31) 69.6% (71)
(13) 53.9% (89) NS
(17) 46.1% (76)
(5) 15.2% (25) NS
(24) 84.8% (139)
(2) 96.6% (57) 0.002
(26) 80.0% (104)
(12) 88.5% (92) NS
(16) 78.7% (59)
(7) 89.1% (57) NS
(23) 81.6% (102)
(29) 81.0% (124)
(11) 88.0% (81) NS
(24) 81.8% (108)
(1) 83.3% (5)
(34) 43.9% (138) NS
(30) 56.1% (176)
iography; LAD  left anterior descending coronary artery; LCx  left
nary artery.istics
ps on
ap Ab
16.9%
27.8%
12.7%
12.2%
18.5%
17.9%
12.8%
6.3%
30.4%
43.3%
56.7%
17.2%
82.8%
3.4%
20.0%
11.5%
21.3%
10.9%
18.4%
19.0%
12.0%
18.2%
16.7%
53.1%
46.9%ho underwent CTA for clinical indications, with only 49%
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CTA Stent Gap November 17, 2009:1949–59ndergoing CCA, rather than a prospective, consecutive series
f patients who underwent stenting with follow-up CCA and
TA. Consequently, there is significant selection bias, and the
tudy very likely overestimates the incidence of SF or OF in the
eneral population of stented patients. Reflecting the problems
nherent in tertiary referral centers, in which data regarding
tents implanted elsewhere may not be available, is the incom-
lete stent implantation data in those who underwent CCA.
owever, sufficient numbers of stents were available for mean-
ngful analysis, and this study is the first to address this topic in
large series of patients. SF and OF cannot be absolutely
onfirmed in the absence of postmortem examination. How-
ver, the absence of other plausible explanations, the 46%
ncidence of ISR in stent gaps, and the 28% association of stent
aps with ISR support the pathologic significance of this
bservation.
linical implications. The incidence of stent gaps with
ossible fracture or OF in a large series of stents evaluated
y CTA and CCA was 16.9%, representing 28% of the total
SR population; ISR was present in 46% of SF/OF. This
ery strong association of stent gaps with ISR suggests that,
n patients with drug-eluting stents, it may not be failure of
he drug-eluting compound to prevent neointimal hyper-
lasia that is responsible for all ISR, but rather lack of
xposure of the arterial segment to the compound at a gap
ite in a substantial number. Greater emphasis on those
actors that promote SF and on manufacturing techniques
hat prevent SF appear to be in order. In overlapping stent
mplantations, IVUS may prove to be a reliable tool for
erifying the accuracy of overlap at the time of insertion.
he inability of catheter angiography to detect stent gaps
nd the highly invasive nature of IVUS, and its potential
onfounding by calcified plaque, suggest that CTA is the
iagnostic procedure of choice.
ddress for correspondence: Dr. Harvey S. Hecht, Lenox Hill
eart and Vascular Institute, 130 East 77th Street, New York,
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